Diabetes Blood Test Distributor GlycoMark Agrees To Pay $195,000 To Settle False Claims Act Allegations
PHILADELPHIA—United States Attorney Jacqueline C. Romero announced that GlycoMark, Inc., a joint-venture subsidiary owned by Toyota Tsusho Corporation, Toyota Tsusho America, Inc., and Nippon Kayaku Co., Ltd., has agreed to pay $195,000 to resolve allegations that it violated the False Claims Act by encouraging its customers to submit claims for the GlycoMark test after the test was no longer approved for reimbursement to Medicare and Medicaid.
Action Details
- Date:March 30, 2023
- Agency:U.S. Attorney’s Office, Eastern District of Pennsylvania
-
Enforcement Types:
- Criminal and Civil Actions